SpringWorks Therapeutics Inc.

12/06/2021 | Press release | Distributed by Public on 12/06/2021 05:32

SpringWorks Therapeutics Announces Dosing of First Patient in Phase 1b/2 Trial Evaluating Nirogacestat in Combination with Elranatamab (PF-06863135) in Patients with Relapsed[...]